Seeking men whose metastatic prostate cancer has responded exceptionally well to therapy that included a medication to decrease testosterone and a medication to prevent growth signals in the body from male hormones including testosterone for a study of interrupting hormone treatment to allow testosterone levels to recover.
Participants in this study will stop taking hormonal medications. Every 12 weeks participants will be assessed. If there is any sign of the cancer growing back the hormone treatment would resume until your doctor feels like it is no longer benefitting you.
What we're hoping for
We are studying whether interrupting hormone therapy for men whose metastatic prostate cancer has responded exceptionally well to the treatment will allow testosterone levels to recover and improve their quality of life.
ClinicalTrials.gov Identifier: NCT05241860